Posted on

Mylan Waives Exclusive U.S. Distribution Rights for Potential COVID-19 Therapy

Posted on
pharmaceuticals

U.S. drugmaker Mylan NV said it had waived its exclusive U.S. distribution rights to its generic version of HIV treatment Kaletra, which is currently being tested against the coronavirus. The move would make other drugmakers eligible to seek U.S. approval for their generic versions of the drug and boost supply, which would help in case…

Read more